[go: up one dir, main page]

FI87230B - Serumfritt vaextmedium och dess anvaendning. - Google Patents

Serumfritt vaextmedium och dess anvaendning. Download PDF

Info

Publication number
FI87230B
FI87230B FI875793A FI875793A FI87230B FI 87230 B FI87230 B FI 87230B FI 875793 A FI875793 A FI 875793A FI 875793 A FI875793 A FI 875793A FI 87230 B FI87230 B FI 87230B
Authority
FI
Finland
Prior art keywords
serum
plant medium
concentration
medium according
free plant
Prior art date
Application number
FI875793A
Other languages
English (en)
Finnish (fi)
Other versions
FI875793A (fi
FI875793A0 (fi
FI87230C (sv
Inventor
Kjell Bertheussen
Original Assignee
Medi Cult As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medi Cult As filed Critical Medi Cult As
Publication of FI875793A0 publication Critical patent/FI875793A0/fi
Publication of FI875793A publication Critical patent/FI875793A/fi
Publication of FI87230B publication Critical patent/FI87230B/fi
Application granted granted Critical
Publication of FI87230C publication Critical patent/FI87230C/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/0018Culture media for cell or tissue culture
    • C12N5/0037Serum-free medium, which may still contain naturally-sourced components
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/12Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
    • C12N2500/14Calcium; Ca chelators; Calcitonin
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00Specific components of cell culture medium
    • C12N2500/05Inorganic components
    • C12N2500/10Metals; Metal chelators
    • C12N2500/20Transition metals
    • C12N2500/24Iron; Fe chelators; Transferrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Claims (11)

1. Serumfritt växtmedium bestäende av ett basalmedium för cel 1kulturer, säsom RPMI 1640/HEPES/NaHC03 samt eventuellt spärämnen som är nödvändiga för cellväxt, säsom Zn, Cu, Mn, Ni, Ai, Cr, Co och/eller Se, vilket växtmedium är buffrat i ett pH-omräde inom 7,0 - 7,8, kännetecknat därav, att växtmediet ytterligare bestär av ett otoxiskt järnkelat, där järnets koncentration är 1 - 10 μΜ, samt ett överskott av en eller fler i och för sig kända, otoxiska kelatorer och citronsyra/citrat i en koncentration, som är minst tre gänger sä stor som den totala koncentrationen av kelatorerna, samt aurintrikarboxylsyra 0,5 - 6 μΜ.
2. Serumfritt växtmedium enligt patentkravet 1, kännetecknat därav, att aurintrikarboxylsyrans koncentration är 2,4 - 3,6 μΜ.
3. Serumfritt växtmedium enligt patentkravet 1 eller 2, kännetecknat därav, att eventuella spärämnen före-ligger i sädana mängd, att koncentrationen av kelator/kela-torblandningen är 300 - 300 000 gänger större än koncentrationen av de enskilda spärämnena.
4. Serumfritt växtmedium enligt nägot av patentkraven 1-3, kännetecknat därav , att det innehäller ett eller flera ytaktiva ämnen.
5. Serumfritt växtmedium enligt nägot av patentkraven 1-3, kännetecknat därav, att det ytterligare innehäller växtfaktorer säsom D-glukos, L-glutamin, Na-pyruvat, insulin och etanolamin.
6. Serumfritt växtmedium enligt patentkravet 5, kännetecknat därav, att det ytterligare innehäller växtfaktorer, säsom vitaminer och icke-proteiniska hormoner. 87230
7. Serumfritt växtmedium enligt nägot av patentkraven 1-6, kännetecknat därav, att det innehäller ett basal-medium med en koncentration pä 2,5 g/1 NaHC03 och 20 mM HEPES.
8. Serumfritt växtmedium enligt nägot av patentkraven 1-7, kännetecknat därav, att den använda kelatorn är EDTA.
9. Koncentrat av serumfritt växtmedium för användning tili framställning av vattenhaltigt serumfritt växtmedium enligt nägot av patentkraven 1-6, kännetecknat därav, att det bestär av ett koncentrat av enskilda beständsdelar, företrädesvis 1000 gängers koncentration, bestäende av 2.4 - 3,6 mM Fe-EDTA och 0,2 - 1,2 mM Na2 EDTA samt 32 - 48 mM citronsyra/citrat, 0,5 - 6 mM, företrädesvis 2.4 - 3,6 mM, aurintrikarboksylsyra, samt eventuellt metall- joner inom koncentrationsinterval1ena 0,08 - 0,12 mM Zn* , 0,016 - 0,024 mM Cu2+, 0,0008 - 0,0012 mM Mn2+, 0,00016 - 0,00024 mM Ni2+, 0,0016 - 0,0024 mM Al3+, 0,0008 - 0,0012 mM Cr3+, 0,00016 - 0,00024 mM Co2+ och 0,008 - 0,012 mM Se*+, vilken blandning är buffrad i pH-om- rädet 4,5 - 5,0.
10. Koncentrat av ett serumfritt växtmedium enligt patent-kravet 9, kännetecknat därav, att det föreligger i form av en torrämnesblandning.
11. Användningen av ett serumfritt växtmedium enligt nägot av patentkraven 1-7 för undersökning av växtmediumkvalitet, företrädesvis genom användning av cellinjen ECACC 86112001, deponerad vid The European Collection for Animal Cell Cultures den 20 november 1986.
FI875793A 1987-01-09 1987-12-31 Serumfritt växtmedium och dess användning FI87230C (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NO870095A NO162160C (no) 1987-01-09 1987-01-09 Serumfritt vekstmedium, samt anvendelse derav.
NO870095 1987-01-09

Publications (4)

Publication Number Publication Date
FI875793A0 FI875793A0 (fi) 1987-12-31
FI875793A FI875793A (fi) 1988-07-10
FI87230B true FI87230B (fi) 1992-08-31
FI87230C FI87230C (sv) 1992-12-10

Family

ID=19889567

Family Applications (1)

Application Number Title Priority Date Filing Date
FI875793A FI87230C (sv) 1987-01-09 1987-12-31 Serumfritt växtmedium och dess användning

Country Status (16)

Country Link
US (2) US5045467A (sv)
EP (1) EP0274445B1 (sv)
JP (2) JPH0697996B2 (sv)
KR (1) KR880009124A (sv)
AT (1) ATE92098T1 (sv)
AU (1) AU596491B2 (sv)
BR (1) BR8800040A (sv)
CA (1) CA1321961C (sv)
DE (1) DE3882540T2 (sv)
DK (1) DK169765B1 (sv)
ES (1) ES2008411A6 (sv)
FI (1) FI87230C (sv)
IL (1) IL85026A (sv)
IT (1) IT1215675B (sv)
NO (1) NO162160C (sv)
NZ (1) NZ223139A (sv)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1307486C (en) * 1987-10-29 1992-09-15 Michael T. Largen Hybridoma production
SE8801537D0 (sv) * 1988-04-26 1988-04-26 Ellco Food Ab Cellodlingsmedium samt forfarande for dess framstellning
JPH03180175A (ja) * 1989-12-07 1991-08-06 Snow Brand Milk Prod Co Ltd 無血清培地
US5378612A (en) * 1990-05-11 1995-01-03 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Culture medium for production of recombinant protein
WO1993000423A1 (en) * 1991-06-21 1993-01-07 Novo Nordisk A/S Iron chelate culture medium additive
GB9215834D0 (en) * 1992-07-24 1992-09-09 Celltech Ltd Cell culture
DE4313620A1 (de) * 1993-04-26 1994-10-27 Biotechnolog Forschung Gmbh Hamsterzellinien und Verfahren zur Glykoproteingewinnung
US5434185A (en) * 1993-05-17 1995-07-18 The University Of Kentucky Research Foundation Method for inhibiting angiogenesis with aurintricarboxylic acid, its analogues or salts
US5405772A (en) * 1993-06-18 1995-04-11 Amgen Inc. Medium for long-term proliferation and development of cells
US5846529A (en) * 1993-08-23 1998-12-08 Nexell Therapeutics, Inc. Infusion of neutrophil precursors for treatment of neutropenia
US6037174A (en) * 1993-08-23 2000-03-14 Nexell Therapeutics, Inc. Preparation of serum-free suspensions of human hematopoietic cells or precursor cells
US5395822A (en) * 1993-09-20 1995-03-07 Izumi; Yukitoshi Use of pyruvate to prevent neuronal degeneration associated with ischemia
US5593880A (en) * 1994-02-10 1997-01-14 Viratest International, Inc. Dual-state nutritional medium for the transport and maintenance of cells
US5908782A (en) * 1995-06-05 1999-06-01 Osiris Therapeutics, Inc. Chemically defined medium for human mesenchymal stem cells
US6733746B2 (en) 1996-03-12 2004-05-11 Invitrogen Corporation Hematopoietic cell culture nutrient supplement
US6043092A (en) * 1996-03-18 2000-03-28 University Of Pittsburgh Cell culture media for mammalian cells
US6511848B2 (en) * 1996-04-17 2003-01-28 Winfried Albert Process for producing and multiplying lymphocytes
AU4330597A (en) * 1996-08-30 1998-03-19 Life Technologies, Inc. Serum-free mammalian cell culture medium, and uses thereof
US6833271B2 (en) * 1996-12-04 2004-12-21 Medi-Cult A/S Serum-free cell culture media
GB9625175D0 (en) * 1996-12-04 1997-01-22 Medi Cult As Serum-free cell culture media
US5804420A (en) * 1997-04-18 1998-09-08 Bayer Corporation Preparation of recombinant Factor VIII in a protein free medium
US6541256B1 (en) 1999-02-11 2003-04-01 The Schepens Eye Research Institute, Inc. Growth medium for human corneal endothelial cells
ATE384120T1 (de) * 1999-08-27 2008-02-15 Invitrogen Corp Metallbindende verbindungen und deren verwendung in zusammensetzungen für zellkulturmedien
US6767741B1 (en) * 1999-08-27 2004-07-27 Invitrogen Corporation Metal binding compounds and their use in cell culture medium compositions
GB0003231D0 (en) * 2000-02-11 2000-04-05 Medi Cult As Cell culture media
US20030096414A1 (en) * 2001-03-27 2003-05-22 Invitrogen Corporation Culture medium for cell growth and transfection
WO2002099070A2 (en) * 2001-06-04 2002-12-12 Corixa Corporation Compositions and methods for high-level, large-scale production of recombinant proteins
US7087369B2 (en) * 2003-12-17 2006-08-08 The Regents Of The University Of California Cornea preservation medium
US20080085298A1 (en) * 2004-03-12 2008-04-10 Biodel, Inc. Rapid Mucosal Gel or Film Insulin Compositions
US20080096800A1 (en) * 2004-03-12 2008-04-24 Biodel, Inc. Rapid mucosal gel or film insulin compositions
US20080090753A1 (en) 2004-03-12 2008-04-17 Biodel, Inc. Rapid Acting Injectable Insulin Compositions
PL1807504T3 (pl) 2004-11-02 2011-07-29 Ares Trading Sa Bezsurowicza pożywka hodowlana dla komórek ssaczych
US8273553B2 (en) 2004-11-02 2012-09-25 Ares Trading S.A. Production of growth hormone in serum-free cell culture medium for mammalian cells
WO2006071563A2 (en) 2004-12-23 2006-07-06 Medimmune Vaccines, Inc. Non-tumorigenic mdck cell line for propagating viruses
EP1917276B1 (en) 2005-08-26 2018-03-21 Ares Trading S.A. Process for the preparation of glycosylated interferon beta
AU2007205522B2 (en) 2006-01-13 2011-08-11 Two Cells Co., Ltd. Additive for culture medium for use in serum-free culture of animal cell, kit, and use of the additive or kit
ES2668212T3 (es) * 2006-07-13 2018-05-17 Wyeth Llc Producción de factor de coagulación IX con patrón de glucosilación mejorado
CN103361319A (zh) 2006-09-15 2013-10-23 米迪缪尼有限公司 支持病毒生长到高效价的mdck细胞系和采用该细胞系的生物反应器方法
US8361741B2 (en) * 2007-08-29 2013-01-29 Millipore Corporation Serum-free growth medium for Acholeplasma laidlawii and methods for retention testing sterilizing grade filters
CA2738024A1 (en) 2008-09-24 2010-04-01 Medimmune, Llc Methods for purification of viruses
US20110212523A1 (en) * 2008-11-11 2011-09-01 Yukio Kato Differentiation-inducing culture medium additive and use thereof
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
JP5804385B2 (ja) 2010-03-10 2015-11-04 株式会社ツーセル 間葉系幹細胞を含む細胞製剤及びその製造方法
KR102136698B1 (ko) 2012-05-02 2020-07-22 라이프 테크놀로지스 코포레이션 고밀도 성장 및 형질감염 배지 및 발현 인핸서의 독특한 페어링을 사용하는 포유동물 세포들 내의 고수율의 일시적 발현
CA2942770A1 (en) * 2014-03-23 2015-10-01 Advantech Bioscience Farmaceutica Ltda. Enhancement of recombinant protein expression with copper
TW201630622A (zh) 2014-12-16 2016-09-01 美國禮來大藥廠 速效胰島素組合物
US10119117B2 (en) 2016-01-28 2018-11-06 Nanogen Pharmaceutical Biotechnology Co., Ltd Universal, glycosylation enhancer, completely chemically defined medium formulation
WO2018178063A1 (en) * 2017-03-31 2018-10-04 Boehringer Ingelheim International Gmbh Perfusion medium
CN110835622B (zh) * 2018-08-16 2021-04-27 上海药明生物技术有限公司 用于调节哺乳动物细胞乳酸代谢的培养基及其应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4466917A (en) * 1981-02-12 1984-08-21 New York University Malaria vaccine
US4544632A (en) * 1981-06-12 1985-10-01 Yuichi Yamamura Human T cell lines and method of producing same
IL65765A (en) * 1982-05-13 1985-09-29 Israel State Method of preventing virus replication in plants
US4604284A (en) * 1983-09-20 1986-08-05 Hoffmann-La Roche Inc. Homogeneous immune interferon fragment
EP0156169B1 (en) * 1984-02-29 1991-12-18 Asahi Kasei Kogyo Kabushiki Kaisha An aqueous solution of a tissue plasminogen activator dissolved therein at an increased concentration and a method
JPS6158584A (ja) * 1984-08-30 1986-03-25 Ube Ind Ltd 細胞増殖促進剤及び細胞増殖促進方法
JP2967117B2 (ja) * 1989-03-14 1999-10-25 旭化成工業株式会社 電子線硬化型導電性ペースト組成物

Also Published As

Publication number Publication date
IL85026A0 (en) 1988-06-30
JPS63279786A (ja) 1988-11-16
BR8800040A (pt) 1988-08-02
EP0274445A2 (en) 1988-07-13
JP2524313B2 (ja) 1996-08-14
ES2008411A6 (es) 1989-07-16
DK678687D0 (da) 1987-12-22
DK169765B1 (da) 1995-02-20
IT8819024A0 (it) 1988-01-08
FI875793A (fi) 1988-07-10
NO870095L (no) 1988-07-11
CA1321961C (en) 1993-09-07
US5045467A (en) 1991-09-03
IL85026A (en) 1992-09-06
FI875793A0 (fi) 1987-12-31
KR880009124A (ko) 1988-09-14
DE3882540D1 (de) 1993-09-02
JPH06292570A (ja) 1994-10-21
ATE92098T1 (de) 1993-08-15
NZ223139A (en) 1991-09-25
EP0274445A3 (en) 1989-12-13
JPH0697996B2 (ja) 1994-12-07
AU596491B2 (en) 1990-05-03
NO162160C (no) 1989-11-15
DK678687A (da) 1988-07-10
AU1011588A (en) 1988-07-14
NO162160B (no) 1989-08-07
EP0274445B1 (en) 1993-07-28
IT1215675B (it) 1990-02-22
DE3882540T2 (de) 1993-11-18
US5045454A (en) 1991-09-03
FI87230C (sv) 1992-12-10
NO870095D0 (no) 1987-01-09

Similar Documents

Publication Publication Date Title
FI87230B (fi) Serumfritt vaextmedium och dess anvaendning.
Wigler et al. Tumour promotor induces plasminogen activator
Moore et al. Cytogenetic analysis of human acute and chronic myeloid leukemic cells cloned in agar culture
ES2843073T3 (es) Medio químicamente definido para el cultivo de células madre cancerosas (CSC) que contienen poblaciones de células
EP2505644B1 (en) Atmosphere control composition
Mayer‐Gostan et al. Extraintestinal calcium uptake in the killifish, Fundulus heteroclitus
Reddy et al. Methyl farnesoate stimulates ovarian maturation in the freshwater crab Oziotelphusa senex senex Fabricius
Vincent et al. Effects of oxygen‐free radicals on proliferation kinetics of cultured rabbit articular chondrocytes
Rasey et al. Tumor cell toxicity of stable gallium nitrate: enhancement by transferrin and protection by iron
Reddel et al. Cell cycle effects of iron depletion on T-47D human breast cancer cells
Kajander et al. Effects of selenomethionine on cell growth and on S-adenosylmethionine metabolism in cultured malignant cells
Visha et al. Influence of dietary nanoselenium supplementation on the meat characteristics of broiler chickens
CN105039251A (zh) 一种pH值稳定的淋巴细胞无血清培养基及其制备方法和应用
Glassman et al. Trace metal levels in commercially prepared tissue culture media
Hibbin et al. Antigenic expression and proliferative status of multilineage myeloid progenitor cells (CFU‐GEMM) in normal individuals and patients with chronic granulocytic leukaemia
Uckun et al. Ex vivo elimination of lymphoblastic leukemia cells from human marrow by mafosfamid
Abrahams et al. Assessment of viability of frozen bone marrow cells using a cell‐culture method
Sano et al. The relative resistance of non-cycling cells in 9L multicellular spheroids to spirohydantoin mustard
Kulcsar Apoptosis of tumor cells induced by substances of the circulatory system
Novotny et al. Impact of ascorbic acid on selenium-induced growth inhibition of canine mammary tumor cells in vitro
Sheridan et al. Potentiation of anchorage-independent colony formation by sodium polyanethol sulphonate
Johnstone et al. Effects of Sulfur-containing Hydantoin Derivatives on Metabolism of Ehrlich Ascites Carcinoma
RU2228354C2 (ru) Питательная среда для микроклонального размножения картофеля
Ozawa et al. Effects of prostaglandin e on the proliferation and differentiation of leukemic progenitor cells in acute nonlymphocytic leukemia
Kästner et al. A granulopoiesis inhibitor partially purified from large-scale serum-free cultures of porcine leukocytes

Legal Events

Date Code Title Description
FG Patent granted

Owner name: MEDI-CULT A/S

MA Patent expired